TrialJournal of acquired immune deficiency syndromes (1999)2019

Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).

Albert Y Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.